GLAS

Glass House Brands Inc.

Healthcare · Drug Manufacturers - Specialty & Generic

6.80$ +0.5% vs. previous close Closing price · As of: Sep 28, 2026

Statements

Income Statement

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures per share in USD.

Tick rows to compare them in a chart (up to 4)

Income Statement GLAS
Line item	2022	2023	2024	2025
Revenue	1.24	2.27	2.61	2.23
Cost of Revenue	0.94	1.13	1.35	1.29
Gross Profit	0.30	1.14	1.27	0.94
Selling, General & Administrative	0.86	0.89	0.91	0.93
Total Operating Expenses	1.98	2.22	2.46	2.41
Operating Income	-0.74	0.05	0.16	-0.18
Interest Expense	0.11	0.14	0.12	0.09
Pre-Tax Income	-0.55	-1.24	0.15	-0.21
Net Income	-0.48	-1.39	0.01	-0.36

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.